Company Research
Whether you are exploring new sales opportunities or researching a new investment, FirstRain provides unique insight into important developments for Celgene Corporation (CELG). You can receive reports or configure the research engine for yourself.
Report On:
Celgene Corporation (CELG)
HEALTHCARE - Drugs - Biotechnology
Generated: Thursday September 15, 2011 04:07 AM
|
|
||||||||||||||||||
Quotes About Celgene Corporation
-
Acceleron Pharma starts Phase 1 ACE-536 trial
ACE-536 is our fourth internally discovered, developed and manufactured drug to enter human clinical trials in the past five years,"
- John Knopf -
Phase 1 Study of ACE-536 Initiated
By affecting production of red blood cells via a mechanism distinct from erythropoiesis stimulating agents, ACE-536 may become an option for patients for whom current therapies are ineffective,"
- John Knopf -
SMC OKs Celgene's Vidaza for MDS
Each year in Scotland, approximately 200 people are diagnosed with MDS and this positive SMC decision will have a profoundly positive effect on their lives,"
- David Hall -
Voice: cutting costs, not trees
The way we separate ourselves from our competition is through our customer service. Our customers are our first and primary focus; everything else is secondary,"
- Jay Mitiguy -
Edge Therapeutics Appoints Dr. Sol J. Barer to Board of Directors
We are honored that Dr. Barer is joining our board during this exciting and early stage of our company's development,"
- Brian A. Leuthner
Latest Company Intelligence
-
Using Celgene Option Income To Speculate On Biotech
Seeking Alpha | Sep 13,'11
I am setting a strategy to buy four speculative biotechnology stocks. The net position to my portfolio will be 1% - 2% in total. I will be selling Celgene Corporation ( CELG ) covered calls and using the option premium to buy a basket of speculative names. Celgene has a vast and growing biotechnology pipeline . I want to buy the basket of four speculative names in the hope one -
Celgene (CELG) -- An Attractive Buyout Candidate At Current Levels
Forbes Blog | Sep 8,'11
[1]Image via Wikipedia Article by Frank M. Bifulco, CFA - Alcott Capital Management Celgene Corp (CELG [2]) is one of the few biotech or pharmaceutical companies able to grow the top line, maintain an excellent R&D pipeline, and also sell at a dirt-cheap valuation.
FirstRain customers use intelligent business search to find actionable insights about companies, management, and industries. You can review company briefs, quickly research a new idea or opportunity, generate personalized industry reports, or set up alerts on reasons to call. Be sure to view our sample reports below.
